SCHEMBL13153383

SCHEMBL13153383

CCn1cc(N)c2ccc(Cl)cc21

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 8/20 0.38
▸ HTR6 P50406 2/20 0.38
▸ CYP3A4 P08684 3/20 0.37
▸ NR4A2 P43354 2/20 0.37
▸ TSHR P16473 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MAT2A P31153 2/20 0.36
▸ SCN2A Q99250 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ SOS2 Q07890 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13153267 0.86 PTGER4 (0.42) CYP3A4TSHRALDH1A1ALOX15SMN1; SMN2
SCHEMBL18015855 0.79 KCNH2 (0.46) KCNA3HTR6MAT2ACNR1PTGER4
SCHEMBL13152683 0.79 LMNA (0.41) HTR6CNR1
SCHEMBL13153386 0.77 KIF11 (0.44) KCNA3HTR6ALDH1A1MAT2ACNR1
SCHEMBL13806217 0.77 CYP3A4 (0.41) HTR6CYP3A4NR4A2TSHRALDH1A1
SCHEMBL2884083 0.76 ALDH1A1 (0.50) CYP3A4TSHRALDH1A1SMN1; SMN2TDP1
SCHEMBL2642676 0.74 KDM4E (0.48) NR4A2TSHRALDH1A1SMN1; SMN2TDP1
SCHEMBL18014779 0.74 PTGER1 (0.46) KCNA3HTR6SCN2ACNR1PTGER4
SCHEMBL13806314 0.74 NR4A2 (0.50) NR4A2ALDH1A1SMN1; SMN2TDP1
SCHEMBL13152546 0.73 CYP1A2 (0.41) TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 — — WO disclosed
Send feedback